Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • On this World Environment Day, Viral Desai plants 4,000 trees under ‘Satyagraha against Pollution’ Business
  • Luxury on a Budget: Cranberries Are the Secret to Perfect Gifts Business
  • Digisharks Communications Pvt Ltd hosted a fantastic Diwali party for its employees and announced the National Achievers Awards 2022 Lifestyle
  • Faalcon Concepts Secures ₹101.93 Crore Mega Order for Splendor ONYX Project in Noida Business
  • Reseal honours top businesses with Maharashtra Business Icon Awards Business
  • Personal Loan in India: A Comparison Guide
 Finance
  • How Inflation and Medical Costs Are Influencing Health Insurance Premiums Health
  • Tamas Talent announces Real Imperial Awards 2023; Check out the winners  Lifestyle

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Hafele Kabi-Flow Redefines Access and Security for Modern Furniture Business
  • Apex Ecotech Limited Reports a Strong 331.85% HoH Surge in EBITDA, Reaching ₹897.78 Lakhs in H2 FY25 Business
  • Mopshop Distribution Limited’s IPO Opens from August 19, 2026 to August 21, 2026; Issue Price Fixed at Rs. 138 Per Equity Share Business
  • KLM Axiva Finvest to Raise Up to Rs 15,000 Lakhs via NCDs Business
  • Wonderchef leads the coffee revolution in India Business
  • Three M Paper Boards Ltd’s Rs. 39.83 crore IPO opens on July 12 Business

Recent Posts

  • K J Somaiya Institute of Management Confers Degrees on 1,244 Students
  • Adisoft Technologies Wins MSMECCII Bharat Ratna Award 2026 and Best Sustainable Company of the Year 2026
  • Heat City: Antarpath – Chapter One Trailer Unveiled at Mumbai Launch Event, Promises a High-Stakes Crime Saga
  • Madhavaa Crafts Limited Sets Sights on NSE Emerge Listing with DRHP Filing
  • Shikshagraha’s Mothers of Courage Named Finalist at UN SDG Action Awards 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Few Weeks to Go: Zak Doors & Windows Expo 2025 Set to Showcase Practical, Future-Ready Solutions for India’s Evolving Building Industry Business
  • Manish Kumar Agrawal: Driving the Future of Digital Transformation and Gen AI Strategy Technology
  • Homes With A Pulse: Why 2026 Interiors Are Choosing Memory Over Minimalism Lifestyle
  • Killer Cough Syrup Coldrif Ban Sparks Drug Reform National
  • Boosting Employability, Industry Collaborations Take Center Stage in Indian Higher Education Education
  • Dr. Sahil Lal: A Philanthropist with a Heart of Gold, Providing Hope and Healing to Those in Need Business
  • Bonanza Wealth Management Research gives a Buy Call on Radhika Jeweltech Ltd Business
  • NONSTOP sets a new standard as India’s first and largest modern retail format for mobility solutions Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme